Home  >  Products  >  MAP4 (microtubule-associated protein 4) Blocking Peptide (the N terminal of MAP4)(100ug)
MAP4 (microtubule-associated protein 4) Blocking Peptide (the N terminal of MAP4)(100ug)

MAP4 (microtubule-associated protein 4) Blocking Peptide (the N terminal of MAP4)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MAP4 Antibody (ARP60314_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60314
Size: 100ug
Weight: 121kDa
Gene: 4134
Format: Lyophilized powder
Target: MAP4 is a major non-neuronal microtubule-associated protein. This protein contains a domain similar to the microtubule-binding domains of neuronal microtubule-associated protein (MAP2) and microtubule-associated protein tau (MAPT/TAU). This protein promotes microtubule assembly, and has been shown to counteract destabilization of interphase microtubule catastrophe promotion. Cyclin B was found to interact with this protein, which targets cell division cycle 2 (CDC2) kinase to microtubules. The phosphorylation of this protein affects microtubule properties and cell cycle progression.
Alternative names: DKFZp779A1753; MGC8617
See Full Product Listings >